Register for OBR daily


IMS_White_300x250

To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

CBMG $22.99 3.2600 +16.52%
NKTR $11.82 1.2700 +12.04%
SGEN $36.90 1.7000 +4.83%
EXEL $4.19 0.1600 +3.97%
MDVN $76.72 2.4900 +3.35%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

GALT $5.69 -0.4500 -7.33%
TGTX $7.37 -0.5400 -6.83%
IMNP $3.80 -0.2400 -5.94%
CTIC $2.44 -0.1500 -5.79%
EPZM $29.64 -1.6800 -5.36%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next > | Last >>

Blood Test Predicts Suicide Risk, Study Suggests

(FoxNews.com/LiveScience) July 31, 2014 - A new gene linked to suicide risk has been discovered, and researchers say the finding could lead to a blood test that predicts a person's risk of attempting suicide.
read article 



BioMarin Sells Priority Review Voucher to Regeneron

(Morningstar/Dow Jones Newswires) July 30, 2014 - Regeneron Pharmaceuticals Inc. and Sanofi SA are spending $67.5 million on a novel bet they hope will help them speed their experimental cholesterol drug to the market.
read article 



Khosla-Backed Startup Hopes to Bring Doctors to Patients' Mobiles

(Reuters) July 31, 2014 - HealthTap Chief Executive Officer Ron Gutman believes paying the doctor a visit is expensive and time-consuming.
read article 



Interest Surges in Medicare Bundled-Payment Initiative

(Modern Healthcare) July 31, 2014 - Medicare will nearly triple the number of hospitals and medical groups that are candidates to test bundled payments, one of the health reform law's efforts to revamp healthcare financing.
read article 



Rutherford's CGI Gets Up Close and Personal About Cancer

(NorthJersey.com) July 31, 2014 - Cancer Genetics, Inc., a DNA-based cancer diagnostics company that researches cancer tests and has five patents for hematological, kidney, renal and cervical cancer tests, is in a unique position to have several employees who are fighting cancer or have family members who battled the disease.
read article 



Epic Sciences Raises $30M For “No Cell Left Behind” Test That Analyzes Circulating Tumor Cells

(MedCity News) July 30, 2014 - With a simple blood test, Epic Sciences can help physicians monitor the condition and severity of a cancer patient’s cancer by analyzing the intricacies of his or her circulating tumor cells.
read article 



Letters: Treatment Choices For Breast Cancer

(New York Times) July 30, 2014 - To the Editor: Re “The Wrong Approach to Breast Cancer” (Sunday Review, July 27): Kudos to Peggy Orenstein for her continuing efforts at educating, illuminating and sharing her own experience with breast cancer and breast reconstruction.
read article 



Sunstroke at the FDA

(Wall Street Journal) July 30, 2014 - U.S. drug regulators ban better sunscreen amid a skin cancer crisis.
read article (paid subscription required) 



Raw Medicare Data Singles Out Radiation Oncology. That’s Misleading.

(KevinMD blog) July 30, 2014 - Almost everyone agrees that transparency in the Medicare payment system will likely lead to more efficient health care delivery with less waste and less fraud. However, thoughtful analysis must be performed so that undue stigmatization will not occur.
read article 



CWRU Gets $1.6 Million Grant For Nursing Program to Increase Patient Participation in Clinical Cancer Trials

(The Plain Dealer [Cleveland, OH]) July 30, 2014 - The National Cancer Institute is giving Case Western Reserve University researchers $1.6 million over five years to develop and nationally test a program designed to help oncology nurses educate cancer patients about clinical trials.
read article 



Novartis Apologises For Not Disclosing Side-Effects of Leukaemia Drugs Sooner

(Reuters) July 31, 2014 - The Japanese unit of Novartis AG apologised on Thursday for failing to report to authorities in a timely manner side-effects of its leukaemia drugs, in the company's latest scandal in the country.
read article 



EMA Approves Eisai's Lenvatinib For Accelerated Assessment in Radioiodine-Refractory Differentiated Thyroid Cancer

(MarketWatch) July 30, 2014 - The European Medicines Agency (EMA) has approved Eisai's request for accelerated assessment of the investigational oral multiple receptor tyrosine kinase (RTK) inhibitor lenvatinib, for the treatment of patients with progressive radioiodine-refractory, differentiated thyroid cancer (RR-DTC).
read article 



AstraZeneca Steps Up Push Into Cancer Immunotherapy

(Reuters) July 31, 2014 - AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumor types.
read article 



Erytech Enrolls First Patient in Phase II Study of ERY-ASP in Pancreatic Cancer

(Pharmaceutical Business Review) July 30, 2014 - ERYTECH Pharma has announced the enrollment of the first patient in its Phase II study with ERY-ASP in second line treatment of patients affected by pancreatic cancer.
read article 



Target Growth-Driving Cells Within Tumors, Not Fastest-Proliferating Cells, New Study Suggests

(Dana-Farber) July 30, 2014 - A Dana-Farber study shows growth-driving cancer cells may be better targets for therapies than cells that proliferate the fastest within the tumor.
read press release 



Navigators Can Help Guide Breast Cancer Patients Through Care

(Reuters Health) July 30, 2014 - Patient navigators may be able to help steer women with breast cancer through what can be a daunting treatment process, a new study suggests.
read article 



Same Cancer, Different Time Zone

(MD Anderson) July 30, 2014 - Just as no two people possess the same genetic makeup, a recent study has shown that no two single tumor cells in breast cancer patients have an identical genome.
read press release 



Cause of Rare Childhood Cancer Discovered

(University of Aberdeen [Scotland]) July 31, 2014 - Scientists have made a breakthrough in understanding the cause of a rare childhood muscle cancer, called Rhabdomyosarcoma (RMS).
read press release 



Transplantation Shown to Be Highly Effective in Treating Severe Combined Immunodeficiency

(MSKCC/On Cancer blog) July 31, 2014 - A study shows that treatment of severe combined immunodeficiency (SCID) with stem cell transplantation is very effective, especially if done early.
read article 



Researchers See Promise For Two New Therapies For Mantle Cell Lymphoma After Discovering Why Tumors Can Become Resistant to a Newly Approved Treatment

(Weill Cornell) July 31, 2014 - A research team led by Weill Cornell Medical College has revealed key insight into why late resistance to ibrutinib occurs. And it has shown in preclinical studies that two different drug-treatment strategies may be useful for patients in whom the drug does not work.
read press release 



New NICE Knockback For Celgene Myeloma Drug

(PharmaTimes [UK]) July 31, 2014 - The National Institute for Health and Clinical Excellence is consulting once again on the use of Celgene’s Revlimid (lenalidomide) in the treatment of multiple myeloma following one prior treatment with Johnson & Johnson’s Velcade (bortezomib), as it issued a second draft guidance not recommending it in this use.
read article 



Johnson & Johnson Pulls Hysterectomy Device From Hospitals

(Wall Street Journal) July 30, 2014 - Johnson & Johnson, which already suspended sales of a surgical tool that has been blamed for spreading a dangerous cancer in women, now plans to tell doctors world-wide to return any devices currently on shelves.
read article (paid subscription required) 



Prostate Cancer Probe to Ease Impotence Opposed by Panel

(BloombergBusinessweek) July 31, 2014 - EDAP TMS SA, the maker of an ultrasound device to treat prostate cancer with lower rates of erectile dysfunction, lost almost half its market value after the product failed to win a U.S. advisory panel’s backing.
read article 



Amgen Plans to Cut Up to 2,900 Jobs

(MarketWatch/Dow Jones Newswires) July 30, 2014 - Amgen Inc. said it plans to reduce its global workforce by 12% to 15% and close facilities in two states as part of a restructuring that aims to focus resources on developing new drugs.
read article 



AstraZeneca Buys Almirall Lung Drugs for Up to $2.1 Billion

(Reuters) July 30, 2014 - AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion for the rights to Spanish group Almirall's lung drugs.
read article